α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy

Molecular Pharmaceutics
Himanshu BhattSwati Biswas

Abstract

This study involves development of a dendrimer-based nanoconstruct by conjugating α-tocopheryl succinate (α-TOS) and polyethylene glycol (PEG) on a poly(amidoamine) dendrimer (G4 PAMAM) to improve intracellular delivery of a poorly water-soluble chemotherapeutic drug, paclitaxel (PTX). The conjugates were characterized by NMR, and PTX-loaded nanocarriers (G4-TOS-PEG-PTX) were evaluated for hydrodynamic diameter, polydispersity index (PDI), zeta potential, percentage encapsulation efficiency (%EE), and percentage drug loading (%DL). A hemolysis study was performed, which indicated that the synthesized dendrimer conjugates were not toxic to red blood cells; hence, they were biocompatible. A cellular uptake study in (B16F10 and MDA MB231) monolayer cells and 3D spheroids showed that α-TOS conjugation improved the time dependent uptake of nanosized dendrimer conjugates. The cell viability assay revealed that G4-TOS-PEG-PTX enhanced the cytotoxicity of PTX as compared to free PTX and PTX-loaded G4-PEG (G4-PEG-PTX) at tested concentrations. Correspondingly, the α-TOS-anchored dendrimer induced more apoptosis as compared to free PTX and G4-PEG-PTX. Moreover, the fluorescently labeled G4-TOS-PEG penetrated deeper into MDA MB231 3D sphe...Continue Reading

References

Jan 1, 1996·Journal of Biomedical Materials Research·J C RobertsR T Zera
Feb 1, 1997·Prostaglandins, Leukotrienes, and Essential Fatty Acids·P Ottino, J R Duncan
Jan 29, 2002·Surgery·Mokenge P MalafaMichele King
May 2, 2008·Advanced Drug Delivery Reviews·Jesse B Wolinsky, Mark W Grinstaff
Jun 12, 2009·International Journal of Nanomedicine·Evelina MieleSilverio Tomao
Sep 28, 2010·Advanced Drug Delivery Reviews·Kazuo Maruyama
Mar 30, 2011·Current Drug Targets·Prashant KesharwaniNarendra K Jain
Mar 1, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Kanwaldeep K GillSami Nazzal
May 9, 2012·Methods in Molecular Biology·Kateryna KyrylkovaChrissa Kioussi
Jul 17, 2012·Cancer Letters·Lan Feng, Russell J Mumper
Jan 10, 2013·Apoptosis : an International Journal on Programmed Cell Death·Lubomir ProchazkaJiri Neuzil
Mar 15, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yuanyuan GuoZhiping Zhang
Nov 13, 2013·The Breast : Official Journal of the European Society of Mastology·Elvin Blanco, Mauro Ferrari
Mar 19, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nicolas DuhemVéronique Préat
Feb 14, 2015·International Journal of Nanomedicine·Rashmi H PrabhuMedha D Joshi
Aug 4, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Ahmed Abu-FayyadSami Nazzal
May 24, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Sri Vishnu Kiran RompicharlaSwati Biswas

❮ Previous
Next ❯

Citations

Dec 13, 2019·Macromolecular Bioscience·Tingting XiaoMingwu Shen
Jul 18, 2020·Organic & Biomolecular Chemistry·Andrzej S SkwareckiMaria J Milewska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.